Call Today For A Free Consultation

Tirzepatide is a novel glucagon-like peptide-1 (GLP-1) receptor agonist and glucagon receptor agonist. It is being studied for its potential in the treatment of type 2 diabetes and obesity.

1. Blood Sugar Control: Tirzepatide helps control blood sugar levels by increasing insulin secretion and reducing glucose production.

2. Weight Loss: In its higher doses, Tirzepatide has demonstrated significant weight loss effects, making it potentially beneficial for individuals with obesity.

GLP-1 receptor agonists, like tirzepatide, work by mimicking the effects of the naturally occurring hormone GLP-1. This hormone plays a role in regulating blood sugar levels by stimulating insulin secretion, slowing down gastric emptying, and reducing glucagon secretion.

Tirzepatide is designed to provide both GLP-1 and glucagon receptor agonism. This dual action is believed to offer potential benefits for glycemic control, weight management, and other metabolic factors.